- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06885294
Physiotherapy/hypnosis for AVC Patients
March 25, 2025 updated by: Audrey Vanhaudenhuyse, University of Liege
Impact of Physiotherapy Combined to Hypnosis on Superior Limb Functional Capacities of AVC Patients
Impact of physical therapy with hypnosis on the functional capacity of the upper limb in stroked patients.
Study Overview
Status
Enrolling by invitation
Conditions
Detailed Description
The cerebrovascular accident (CVA) is a pathology generating many disabled people.
Physiotherapy is one of the usual rehabilitation techniques for a patient with sequelae of ischemia or cerebral hemorrhage.
Combined with another therapeutic approach, hypnosis, it could increase the patient's motor performance.
Study Type
Interventional
Enrollment (Estimated)
84
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Liège, Belgium, 4000
- GIGA Science and Perception Research Group CHU Liège
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adults aged 18 to 80 years old
- Having experienced a stroke more than 3 months ago
- Understanding and proficient in the French language
- Having a functional capacity deficit in at least one of the two upper limbs
- Being able to independently travel to the Yerne medical center for necessary study appointments.
Exclusion Criteria:
- Being under 18 or over 80 years old
- Having a history of upper limb injuries (fractures, prosthetics, etc.)
- Having Wernicke's aphasia (language comprehension disorder)
- Having frontal lobe syndrome
- Undergoing chemotherapy
- Having respiratory disorders (respiratory failure of more than 70%) or receiving oxygen therapy
- Having epilepsy
- Having dementia
- Having untreated hearing impairments
- Being diagnosed with schizophrenia or paranoïa
- Experiencing significant concentration difficulties
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group 1 receiving physiotherapy only
Stroke patients will receive physiotherapy of upper limbs
|
Stroke patients will be randomly assigned to join one of the three groups.
The first group will undergo a pre-treatment evaluation, receive 6 sessions of physiotherapy (2 sessions per week, approximately 20-30 minutes each), and undergo a post-treatment evaluation after 1 month.
After another month without any treatment, they will undergo a third and final assessment.
All evaluations will last approximately 1 hour.
|
|
Experimental: Group 2 receiving combined physiotherapy and hypnosis
Stroke patients will receive physiotherapy of upper limbs under hypnosis
|
Stroke patients will be randomly assigned to join one of the three groups.
The second group will undergo a pre-treatment evaluation, receive 6 sessions of physiotherapy combined with hypnosis (2 sessions per week, approximately 20-30 minutes each), and undergo a post-treatment evaluation after 1 month.
Patients will continue their standard physiotherapy care during these 4 weeks.
After another month without any treatment, they will undergo a third and final assessment.
All evaluations will last approximately 1 hour.
|
|
Experimental: Waitlist group 3 receiving delayed combined physiotherapy and hypnosis
Stroke patients will receive physiotherapy of upper limbs under hypnosis one month after the other groups
|
The control group will be assessed initially and then after 4 weeks.
After the second assessment, they will receive 6 sessions of physiotherapy combined with hypnosis (2 sessions per week, approximately 20-30 minutes each), and undergo a post-treatment evaluation after 1 month.
All evaluation sessions will last approximately 1 hour.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of joint ranges of motion
Time Frame: 8 weeks
|
Measurement of shoulder (flexion, extension, abduction, internal rotation, external rotation), elbow (flexion, extension), wrist (flexion, extension)
|
8 weeks
|
|
assessment of spasticity
Time Frame: 8 weeks
|
Measurement of muscle activation on Ashworth scale (extension and flexion of shoulder, elbow, wrist, fingers, thumb) => 0%-100% (a higher score means a worse outcome)
|
8 weeks
|
|
functional tests for the upper limb
Time Frame: 8 weeks
|
Stroke Upper Limb Capacity Scale (SULCS) => 0%-100% (a higher score means a better outcome)
|
8 weeks
|
|
scales for assessing disability and functional independence
Time Frame: 8 weeks
|
Functional Independence Measure (FIM) from complete dependence to independence => 0%-100% (a higher score means a better outcome)
|
8 weeks
|
|
evaluation of muscle strength
Time Frame: 8 weeks
|
Measurement of pathological upper limb strength on MRC scale by group/time/joint/movement => 0%-100% (a higher score means a better outcome)
|
8 weeks
|
|
Box and Block Test (BBT)
Time Frame: 8 weeks
|
Measurement of manual dexterity and motor skills by moving blocks into box comparing healthy upper limb with pathological upper limb => 0%-100% (a higher score means a better outcome)
|
8 weeks
|
|
Modified Rankin Scale (mRS)
Time Frame: 8 weeks
|
Measurement of degree of disability => 0%-100% (a higher score means a worse outcome)
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Audrey Vanhaudenhuyse, PhD, University of Liege
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 18, 2023
Primary Completion (Estimated)
December 30, 2025
Study Completion (Estimated)
July 30, 2026
Study Registration Dates
First Submitted
April 8, 2024
First Submitted That Met QC Criteria
March 19, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 30, 2025
Last Update Submitted That Met QC Criteria
March 25, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2022-306
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
Clinical Trials on Physiotherapy
-
Hacettepe UniversityCompleted
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedSubacromial Impingement SyndromeTurkey (Türkiye)
-
Manchester Metropolitan UniversityCompleted
-
Rigshospitalet, DenmarkThe Association of Danish Physiotherapists Research Fund, Denmark; The Jubilee...CompletedTrismus | Oropharyngeal Cancer | Oral Cavity Carcinoma | Adverse Effect of Radiation TherapyDenmark
-
Clinique du Sport, Bordeaux MérignacRecruiting
-
Laura RutkauskienėLithuanian University of Health SciencesActive, not recruitingRespiratory InsufficiencyLithuania
-
University of Nove de JulhoUniversidade Federal do CearaCompletedEdema | ParesthesiaBrazil
-
Ambreen ChohanBlackpool Victoria HospitalCompletedKnee Osteoarthritis | Exercise | Rehabilitation | Physiotherapy | InterventionUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceTerminated